drugset
drugset / Trial / NCT02242370

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

NCT02242370 ↗

Phase 4 Completed 3045 enrolled Boehringer Ingelheim
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Study to assess the effect of Telmisartan on diastolic and systolic blood pressure and to establish the effect on patient's quality of life scores.

Timeline

Start
1999-09
Primary completion
2000-11
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Telmisartan Other / unclassified — —

Indications

essential hypertension